Published Online: Thursday, December 1, 2005

Gold Standard (Tampa, Fla) recently introduced its decision support engine, Alchemy. Developed to fulfill the demand for better clinical information and technology for today's complex health care system, Alchemy is built on the strong framework of the company's flagship product?Clinical Pharmacology. Alchemy supplies built-in functionality, reliable content, and an array of decision support tools, including drug product data, drug images, drug pricing information, professional monographs, patient education and warning labels, and a clinical decision support platform. The product provides users with timely access to critical decision support tools that make possible reduced medication errors, increased productivity, and improved patient care. Key benefits include platform-independent Web service; a highly optimized relational database; clinical screening, which includes route of administration to decrease false positives; and clinical decision support data referential monographs. For more information, visit

Latest Articles
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
Chronic kidney disease incidence has grown faster than many of its common comorbidities such as diabetes and hypertension, and medications may be an underappreciated driver of this growth.
President Barack Obama’s fiscal year 2017 budget proposal calls for an additional $1.1 billion to combat the nation’s spiraling opioid epidemic.
Baxter International is voluntarily recalling intravenous solution due to leaking containers and the potential for particulate matter.
Latest Issues